1 |
Myung YS, Hong SJ, Han JP, Park KW, Ko BM, Lee MS. Effects of administration of a proton pump inhibitor before endoscopic submucosal dissection for differentiated early gastric cancer with ulcer. Gastric Cancer 2017;20:200-206./
|
|
2 |
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1-19./
|
|
3 |
National Comprehensive Cancer Network (US). NCCN Clinical Practice Guidelines in Oncology. Gastric Cancer, Version 2.2017. Fort Washington (PA): National Comprehensive Cancer Network, 2017./
|
|
4 |
National Comprehensive Cancer Network (US). NCCN Clinical Practice Guidelines in Oncology Version Gastric Cancer. Fort Washington (PA): National Comprehensive Cancer Network, 2017./
|
|
5 |
Deng J, Yamashita H, Seto Y, Liang H. Increasing the number of examined lymph nodes is a prerequisite for improvement in the accurate evaluation of overall survival of node-negative gastric cancer patients. Ann Surg Oncol 2017;24:745-753./
|
|
6 |
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer 2017;20:1-19./
|
|
7 |
Woo Y, Goldner B, Ituarte P, Lee B, Melstrom L, Son T, et al. Lymphadenectomy with optimum of 29 lymph nodes retrieved associated with improved survival in advanced gastric cancer: a 25,000-patient international database study. J Am Coll Surg 2017;224:546-555./
|
|
8 |
National Cancer Institute (US). Joinpoint Regression Program, Version 4.4.0.0 (Jan 4, 2017). Rockville (MD): National Cancer Institute, 2017./
|
|
9 |
Huang Y, Feng M, He Q, Yin J, Xu P, Jiang Q, et al. Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients. Medicine (Baltimore) 2017;96:e6721./
|
|
10 |
Wu Z, Zhao J, Gao P, Song Y, Sun J, Chen X, et al. Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis. BMC Cancer 2017;17:275./
|
|